ArticleTranslational oncology2020

Small-Molecule Dual PLK1 and BRD4 Inhibitors are Active Against Preclinical Models of Pediatric Solid Tumors.

Natalie Timme et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.